Christoph Kapitza - Dokumente zum Namen

(1 - 9 von 10

)

Further Improvement in Postprandial Glucose Control With Addition of...

www.scienceopen.com

News · Profile ... MD1, Sibylle Dellweg, MD1, Janina Clair, MD1, Marie-Paule Dain, MD2, Michael A. Nauck, MD3, Klaus Rave, MD1, Christoph Kapitza, MD1.

OASIS

www.abstractsonline.com

Authors: CHRISTOF M. KAZDA, PARAG GARHYAN, YING DING, RONAN P. KELLY, THOMAS A. HARDY, CHRISTOPH KAPITZA, Neuilly-sur-Seine, France, ...

BIM51077, a Novel GLP-1 Analog, Achieves Sustained Improvement in...

professional.diabetes.org

Author: CHRISTOPH KAPITZA. BIM51077, a Novel GLP-1 Analog, Achieves Sustained Improvement in Blood Glucose Control over 28 Days of Treatment In this ...

BIM51077, a Novel GLP-1 Analog, Showed Linear PK and Dose-Response...

professional.diabetes.org

CHRISTOPH KAPITZA. BIM51077, a Novel GLP-1 Analog, Showed Linear PK and Dose-Response Relationship over 7 Days of Treatment This randomized, ...

Long Acting Human GLP-1 Analogue R1583: Safety, Pharmacokinetic and...

professional.diabetes.org

506-P. Author: CHRISTOPH KAPITZA. Long Acting Human GLP-1 Analogue R1583: Safety, Pharmacokinetic and Pharmacodynamic Properties after a Single Administration in Subjects with Type 2 Diabetes The aim of this study was to e The aim of this study was to evaluate the safety, tolerability, pharmacokinetic profile, ...